Terms: = Breast cancer AND SS18, Q15532, 6760, ENSG00000141380, SSXT, SYT AND Treatment
8 results:
1. Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER Program.
Sun YC; Zhao ZD; Yao N; Jiao YW; Zhang JW; Fu Y; Shi WH
BMC Gastroenterol; 2023 Oct; 23(1):354. PubMed ID: 37828423
[TBL] [Abstract] [Full Text] [Related]
2. Sarcoma care in the era of precision medicine.
Wallander K; Öfverholm I; Boye K; Tsagkozis P; Papakonstantinou A; Lin Y; Haglund de Flon F
J Intern Med; 2023 Dec; 294(6):690-707. PubMed ID: 37643281
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
[TBL] [Abstract] [Full Text] [Related]
4. ATR Is a Therapeutic Target in Synovial Sarcoma.
Jones SE; Fleuren EDG; Frankum J; Konde A; Williamson CT; Krastev DB; Pemberton HN; Campbell J; Gulati A; Elliott R; Menon M; Selfe JL; Brough R; Pettitt SJ; Niedzwiedz W; van der Graaf WTA; Shipley J; Ashworth A; Lord CJ
Cancer Res; 2017 Dec; 77(24):7014-7026. PubMed ID: 29038346
[TBL] [Abstract] [Full Text] [Related]
5. Incorporation of treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in breast cancer Patients Treated with Neoadjuvant Chemotherapy.
Bergquist JR; Murphy BL; Storlie CB; Habermann EB; Boughey JC
Ann Surg Oncol; 2017 Nov; 24(12):3510-3517. PubMed ID: 28828583
[TBL] [Abstract] [Full Text] [Related]
6. From morphological to molecular diagnosis of soft tissue tumors.
Miettinen M
Adv Exp Med Biol; 2006; 587():99-113. PubMed ID: 17163160
[TBL] [Abstract] [Full Text] [Related]
7. Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis.
Evans SR; Soldatenkov V; Shchepotin EB; Bogrash E; Shchepotin IB
Int J Oncol; 1999 May; 14(5):979-85. PubMed ID: 10200351
[TBL] [Abstract] [Full Text] [Related]
8. Synthetic analogs of vitamin D3 have inhibitory effects on breast cancer cell lines.
Fioravanti L; Miodini P; Cappelletti V; DiFronzo G
Anticancer Res; 1998; 18(3A):1703-8. PubMed ID: 9673393
[TBL] [Abstract] [Full Text] [Related]
